We-INtervention Among Chinese HIV-serodiscordant Male Couples

Recruiting now · Not applicable

Conditions studied: HIV

In brief

HIV-serodiscordant male couples, in which one male partner is HIV-seropositive and the other is HIV-seronegative, experience multiple risks in HIV care and prevention. As stigma often hinders such couples' access to support and services, leveraging their relational resources is crucial for optimizing their outcomes. The proposed study will assess the efficacy of the three-session We-INtervention focusing on their relationship dynamics to enhance Chinese HIV-serodiscordant male couples' health and well-being. A total of 160 Chinese HIV-serodiscordant male couples (320 individuals: 160 HIV-seropositive and 160 HIV-seronegative) will be randomized at a 1:1 ratio to either the intervention or control arm. In the intervention arm, the We-INtervention will be delivered to both partners of each couple separately. In the control arm, each couple will receive health information pamphlets.

Key facts

Study ID

NCT06639932

Run by

City University of Hong Kong

People needed

320

Starts

2025-09-01

Expected to finish

2027-06-30

Last updated by the study team

2026-01-21

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• both partners are male,
• both partners are aged 18 or above,
• both partners report being in a committed relationship for at least 3 months,
• one partner is HIV-seropositive and the other partner is HIV-seronegative (i.e., serodiscordant couple),
• both partners have disclosed their serostatus to each other, and
• both partners are willing to participate in this study.

You may not qualify if…

• either partner is unable to complete the assessment due to a low education level or to physical or psychological constraints and
• either partner has been diagnosed with another chronic disease (e.g., cancer and coronary heart disease).

Where it is running

• Fangzhouai Garden — Xiamen, Fujian, China (enrolling)
• Guangzhou Yuele Healthcare Service Center — Guangzhou, Guangdong, China (enrolling)
• Community Always There — Shenzhen, Guangdong, China (enrolling)
• Jin Tang Six-Color Rainbow Healthcare Center — Chengdu, Sichuan, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.